These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Molecular Basis for Subtype Specificity and High-Affinity Zinc Inhibition in the GluN1-GluN2A NMDA Receptor Amino-Terminal Domain. Romero-Hernandez A; Simorowski N; Karakas E; Furukawa H Neuron; 2016 Dec; 92(6):1324-1336. PubMed ID: 27916457 [TBL] [Abstract][Full Text] [Related]
10. Correlated conformational dynamics of the human GluN1-GluN2A type N-methyl-D-aspartate (NMDA) receptor. Essiz S; Gencel M; Aktolun M; Demir A; Carpenter TS; Servili B J Mol Model; 2021 May; 27(6):162. PubMed ID: 33969428 [TBL] [Abstract][Full Text] [Related]
11. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator. Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677 [TBL] [Abstract][Full Text] [Related]
12. All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water. Mesbahi-Vasey S; Veras L; Yonkunas M; Johnson JW; Kurnikova MG PLoS One; 2017; 12(6):e0177686. PubMed ID: 28582391 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat recombinant GluN1/GluN2A and GluN1/GluN2B NMDA receptors by ethanol at concentrations based on the US/UK drink-drive limit. Otton HJ; Janssen A; O'Leary T; Chen PE; Wyllie DJ Eur J Pharmacol; 2009 Jul; 614(1-3):14-21. PubMed ID: 19394328 [TBL] [Abstract][Full Text] [Related]